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Aim: To evaluate whether caffeic acid phenethyl ester (CAPE), a flavonoid-like natural compound plentifully found in beeswax, has a
protective effect on diazinon-induced serum cholinesterase (ChE) inhibition in rats.
Materials and methods: Animals were divided into 4 groups. The first animal group was not treated with any substance. The second
animal group was orally given a 200 mg/kg body weight (bw) sublethal dose of diazinon. The third animal group was injected
intraperitoneally with 2.84 mg (10 µmol)/kg bw of CAPE 1 day prior to administration of 200 mg/kg bw of diazinon orally. The fourth
animal group was intraperitoneally injected with 2.84 mg (10 µmol)/kg bw of CAPE 30 min after 200 mg/kg bw of diazinon was orally
administered.
Results: Analysis of the animal blood samples obtained 48 h after diazinon administration revealed that diazinon decreased serum ChE
activity by 75%, while CAPE administration 24 h prior to and 30 min following diazinon application improved serum ChE activity by
25%–32% as compared to levels with diazinon administration only. In silico studies suggest that CAPE prevents diazinon from binding
to butyryl ChE due to a higher binding affinity than that of diazinon.
Conclusion: Our laboratory findings suggest that CAPE plays a protective role against butyryl ChE inhibition by diazinon.
Key words: Organophosphate, diazinon, caffeic acid phenethyl ester, serum cholinesterase, docking

1. Introduction
Organophosphate insecticides (OPI) such as diazinon
(Figure 1) are among the most commonly used compounds
worldwide, and are also taken orally by those committing
suicide in countries dealing with agriculture (1,2). They
inactivate cholinesterase (ChE) by irreversibly binding to
a catalytic serine amino acid residue in the active site of
the enzyme. This in turn impedes the hydrolysis of excess
acetylcholine (ACh), which results in deposition of ACh at
the neurosynapses and neuromuscular junctions disabling
neurotransmission to the muscles. If neurotransmission
to the respiratory muscles is incapacitated by OPIs, death
is not unavoidable if mechanical ventilation and other
supportive measures are provided (3).
Anyone who is exposed to OPIs, such as farmers
dealing with OPIs or workers engaged in the production
of organophosphate (OP) compounds, should regularly go
for blood tests to monitor changes in the ChE levels before
* Correspondence: gokalp07@hotmail.com

serious symptoms occur. Human blood has 2 types of ChE:
1) red blood cell or erythrocyte cholinesterase (EChE), called
true cholinesterase or AChE; and 2) serum ChE (SChE),
called pseudocholinesterase or butyrylcholinesterase
(BChE) (4). EChE is the same enzyme that is found in the
nervous system, lungs, and spleen, while SChE is made in
the liver and also found in the pancreas. SChE readings are
helpful for detecting the early, acute effects of OP poisoning,
while EChE readings are taken into account for long-term
or chronic exposure. In general, blood ChE activity drops
by 15%–25%, 25%–35%, and 35%–50% upon low, moderate,
and severe intoxication by pesticides, respectively (5). The
main treatment for OPI poisoning is the application of
atropine as an ACh receptor blocker. In addition, oxime-like
compounds such as pralidoxime and obidoxime (Figure 1)
are also used as antidotes to prevent OPI from chemically
modifying a catalytic serine amino acid residue in the active
site of ChE (6).
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Figure 1. Structures of pralidoxime (1), obidoxime (2), caffeic
acid phenethyl ester (CAPE) (3), and diazinon (4).

It has been previously determined that caffeic acid
phenethyl ester (CAPE) (Figure 1) plays a substantial
role in ameliorating isoniazid-induced oxidative damage
to red blood cells in rats (7), cadmium-induced cardiac
impairment in rats (8), and cisplatin-induced oxidative
damage to the rat liver (9), as well as controlling superoxide
dismutase stress enzyme activities in diabetic rat retinas
(10) and inducing apoptosis in a dose- and time-dependent
manner in human multiple myeloma cells (11). However,
studies on the effect of CAPE on SChE activity in the
presence of OPIs have not been satisfactorily documented
in the literature. Thus, the main objective of this work is
to provide more insight into the effect of CAPE on SChE
in the presence of diazinon, an OPI, by animal as well as
in silico studies, and to discuss the potential application
of CAPE as an alternative or perhaps complementary
antidote in ameliorating the early or acute phase of SChE
inhibition by diazinon.
2. Materials and methods
2.1. Chemicals
CAPE was obtained from Sigma-Aldrich (St. Louis, MO,
USA). Diazinon (Basudin®) was obtained from Syngenta
(İzmir, Turkey). Ketamine (Ketalar®) was obtained from
Eczacıbaşı (İstanbul, Turkey). Xylazine (Rompun®) was
obtained from Bayer (İstanbul, Turkey).
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2.2. Animal studies
All animal experiments were approved by the Experimental
Animal Ethics Committee of the Health Science Research
and Application Center at Süleyman Demirel University
in Isparta, Turkey. All animal studies were conducted in
accordance with the laws and regulations of the governing
authorities. Animal studies were carried out using 35
young Wistar albino male rats. The rats were divided into
4 groups. The control group of rats (Group I, n = 5) was
orally given corn oil only via orogastric tube. The second
group of rats (Group II, n = 10) was orally given a sublethal
dose of 200 mg/kg body weight (bw) of diazinon (12) in
corn oil, which was prepared by dissolving a required
amount of Basudin in a solution of 60 mg/mL diazinon
in corn oil. The third group of rats (Group III, n = 10)
were intraperitoneally (ip) given 2.84 mg (10 µmol)/kg bw
of CAPE 1 day prior to administration of 200 mg/kg bw
of diazinon, dissolved in corn-oil and orally applied via
orogastric tube (13). The fourth group of rats (Group IV,
n = 10) were ip injected with 2.84 mg (10 µmol)/kg bw of
CAPE 30 min administration of 200 mg/kg bw of diazinon,
dissolved in corn oil and administered via orogastric tube.
2.3. Biochemical analysis
All animals received general anesthesia ip by
administration of 50 mg/kg bw of ketamine and 1 mg/
kg bw of xylazine 48 h after diazinon treatment. Animals
under general anesthesia were surgically decapitated and
cut open with an incision of the median line, and 4 mL of
blood samples were collected from the vena cava inferior
of each incised animal for biochemical analysis. Serum
samples were prepared by the centrifugation of the blood
samples at 4000 rpm. Cholinesterase activities in the serum
samples were measured with an Architect c16000 Abbott
Aeroset® instrument (Abbott Laboratories, Abbott Park,
IL, USA), which applied BCh as the substrate for serum
BChE to yield butyrate and thiocholine as the hydrolysis
products. Thiocholine then reduces hexacyanoferrate(III)
to hexacyanoferrate(II). A decrease in the absorbance of
hexacyanoferrate(III) is directly proportional to the ChE
activity in the sample.
2.4. In silico studies
Docking studies were carried out with AutoDock Vina
v.1.1 (14). The X-ray structure of human BChE in complex
with a tabun molecule, a known inhibitor of the substrate
binding site of the enzyme, was obtained from the Protein
Data Bank, PDB ID: 2WID (15). The X-ray structure
of aged human AChE, in which the catalytic SER200
is phosphoramidylated, in complex with snake venom
fasciculin-II was obtained from the Protein Data Bank,
PDB ID: 2X8B (16). All nonprotein molecules including
tabun, phosphoramidite, fasciculin-II, water, and ions were
removed from PDB structures before docking. Docking
of ligands, including CAPE, pralidoxime, diazinon, ACh,

OĞUZHANOĞLU et al. / Turk J Med Sci

3. Results
From a clinical point of view, it was observed that the
clinical status of some animals poisoned by diazinon
in Groups II, III, and IV deteriorated, with the animals
exhibiting severe symptoms of diarrhea, eye rash,
abdominal distention, and immobility; clinical conditions
culminated in death due to diazinon administration.
Four animals in Group II, to which only diazinon was
administered; 3 animals in Group III, to which CAPE was
given prior to diazinon administration; and 4 animals in
Group IV, to which CAPE was given following diazinon
administration, were reported dead (Table 1).
Mean values for serum ChE activities, expressed as
U/L, and their statistical deviations as referenced to the
control group (Group I) and the surviving animals of
Group II are given in Table 1. In addition, the serum ChE
activities determined for each surviving animal are plotted
in Figure 2. Percent activities for Group II, III, and IV

animals were referenced to the activity of Group I animals,
which was set to 100% in Table 1. As seen in Table 1, the
mean serum ChE activity of Group II animals (22%) was
significantly lower than that of Group I animals (100%). It
was also observed in Group III (50%) and Group IV (43%)
that serum ChE activities improved as compared to Group
II by 25% to 32% upon administration of CAPE prior to
and following diazinon application, respectively (Table 1).
Binding free energies, ΔG°, as a sum of electrostatic
and Van der Waals energies in the gas phase determined
by AutoDock Vina v.1.1 (14), are given in Table 2 for the
most likely bound conformations of ACh, BCh, diazinon,
pralidoxime, and CAPE in the Ser198 catalytic binding
site of BChE. Three binding conformations of CAPE
with binding energies ΔG°1 = –8.2 kcal/mol, ΔG°2 =
–7.9 kcal/mol, and ΔG°3 = –7.2 kcal/mol, respectively;
2 binding conformations of pralidoxime with binding

Mean ChE activity (U/L ± SD)

and BCh, was implemented in a confined grid-box defined
by MGL Tools v.1.5.4 (17). Docked ligands were analyzed
by MGL Tools v.1.5.4. The binding cavity volume of the
receptor species was computed by the online version of the
POCASA v.1.0 software (18). Molecular surface volume of
the ligands was determined by the MSMS module available
in UCSF Chimera v.1.4.1 (19).
2.5. Statistical analysis
Mean ChE activity and standard deviations (SDs) were
computed using serum ChE activity data obtained from
the control group and the animals that survived diazinon
administration. The data groups were compared by oneway ANOVA statistical analysis. Analysis of variance was
determined by Tukey’s honestly significant difference post
hoc analysis.

I

II

III

IV

Animal
group

Figure 2. A graphical presentation of the mean serum BChE
activities (U/L ± SD) in the same animal groups described in
Table 1.

Table 1. Clinical status of animals (dead or surviving) upon diazinon poisoning and mean cholinesterase activities (U/L
± SD) in animal groups determined for the surviving animals.

Clinical status
(dead/surviving)

% ChE activity

Mean ChE activity
(U/L ± SD)

P#

Group I

n=5

0/5

100

369.0 ± 80.8

-

Group II

n = 10

4/6

22

81.5 ± 11.7

<0.0001

Group III

n = 10

3/7

50

185.7 ± 39.8

<0.0001 †

Group IV

n = 10

4/6

43

160.1 ± 12.6

<0.0001 ‡

: Significance between Group II animals (surviving) and the other groups’ animals (surviving).
: Statistically significant change in experimental values of Group III animals (surviving) as compared to Group II
animals (surviving) (P = 0.002).
‡
: Statistically significant change in experimental values of Group IV animals (surviving) as compared to Group II
animals (surviving) (P = 0.023).
#

†
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Table 2. Binding energies, ΔG° (kcal/mol); association binding constants, Ka (L/mol); and molecular
surface volumes, V (Å3), for the most likely bound conformations of acetylcholine (ACh), butyrylcholine
(BCh), diazinon, pralidoxime, and CAPE to the binding site of human BChE.
Ligand

Conformation

V (Å3)

ΔG° (kcal/mol)

Ka (L/mol)

ACh

I

148

–4.3

1.7 × 103

BCh

I

168

–5.2

6.5 × 103

Diazinon

I

275

–6.7

8.2 × 104

I

120

–5.7

1.5 × 104

II

120

–5.5

1.1 × 104

I

255

–8.2

1.0 × 106

II

262

–7.9

6.2 × 105

III

262

–7.2

1.9 × 105

N/A

839

N/A

N/A

Pralidoxime

CAPE
Binding site of BChE
N/A = not applicable.

energies of ΔG°1 = –5.7 kcal/mol and ΔG°2 = –5.7 kcal/
mol, respectively; 1 binding conformation of diazinon
with a binding energy of ΔG° = –6.7 kcal/mol; 1 binding
conformation of BCh with a binding energy of ΔG° =
–5.2 kcal/mol; and 1 binding conformation of ACh with
a binding energy of ΔG° = –4.4 kcal/mol were determined
in the crystal structure of the active site of BChE. Table 2
also lists the corresponding association binding constants
determined by ΔG° = –R T ln Ka, where R is 1.987 cal/
(mol K) and T is 298.15 K, and the volumes are in Å3 for
the binding site and the ligands. Docking binding energies
and the corresponding association constants indicate that
CAPE exhibits the greatest affinity towards the Ser198
catalytic binding site of BChE.
In addition, docking studies were carried out for the
binding site of human BChE; results are shown in Table 3
for diazinon, ACh, and CAPE. CAPE has only 2 binding
modes as compared to the 3 binding conformations for
BChE seen in Table 2. This is because AChE possesses a

narrower binding cleft than that of BChE and, therefore,
CAPE samples have fewer binding conformations in the
binding site of AChE. CAPE binding poses gave rise to
the highest binding affinities with binding energies of ΔG°
= –9.1 kcal/mol and ΔG° = –8.3 kcal/mol. The binding
energy of diazinon in the binding site of BChE was found
to be ΔG° = 7.4 kcal/mol, which means a greater affinity
than that of ACh at ΔG° = –5.0 kcal/mol.
4. Discussion
It was found in our laboratory via animal and computational
experiments that CAPE, shown in Figure 1, exhibits a
protective effect against SChE inhibition by diazinon. In
terms of public health, CAPE is quite safe to use as it is a
natural product found primarily in beeswax and it causes
much less side effects than a synthetic drug (7).
It was determined by animal experiments that diazinon
severely reduced SChE activity by 75% as it was given to
rats; see the results for Group II in Table 1 and Figure 2.

Table 3. Binding energies, ΔG° (kcal/mol), and association binding constants, Ka (L/
mol), for the most likely bound conformations of acetylcholine (ACh), diazinon, and
CAPE to the binding site of human acetylcholinesterase.
Ligand

Conformation

ΔG° (kcal/mol)

Ka (L/mol)

ACh

I

–5.0

4.6 × 103

Diazinon

I

–7.4

2.7 × 105

I

–9.1

4.7 × 106

II

–8.3

1.2 × 106

CAPE
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In the next set of animal experiments, as is observed in
Table 1 and Figure 2, SChE activity decreased by 50% in
Groups III and IV when CAPE was ip injected prior to
and following oral administration of diazinon. The reason
for the application of CAPE prior to diazinon intake
was to see if CAPE would protect the rats from diazinon
poisoning, while CAPE application following diazinon
intake aimed to see its protecting capability in the case of
diazinon poisoning. As a result, it was determined in these
animal experiments that CAPE increased SChE activity by
25% upon diazinon application.
Looking at Table 1 for the number of dead animals in
Groups II, III, and IV, it can be said that CAPE is best able
to protect SChE from the toxic effects of diazinon if it is
applied prior to exposure to OP diazinon, as in the case of
the Group III animals.
The binding free energies given in Table 2 strongly
suggest that CAPE binds to human BChE with the greatest
affinity as compared to other compounds listed in Table 2,
making it a precautionary natural substance, even at lowdosage administrations, to diminish possible inhibition of
SChE by OP compounds.
Molecular surface volumes for the most favorable
docked coordinates of CAPE and ACh are superimposed
in the catalytic binding site of human BChE in Figure
3. As seen in Table 2, surface volumes for CAPE and
ACh are ~260 Å3 and 148 Å3, respectively, which can be
comfortably accommodated in the binding site of BChE,
and are shown in magenta and cyan, respectively, in Figure
3. As diazinon possesses a volume of 275 Å3, larger than
that of ACh, it becomes more difficult to accommodate
CAPE and diazinon together in the binding site. It is
highly likely that the occupation of CAPE in the catalytic
site of BChE prevents diazinon from interacting with

Ser198 and yet maintains the activity of the enzyme at the
minimum levels until ACh accumulates up to competitive
concentrations, at which the enzymatic hydrolysis reaction
with ACh takes place.
It should be noted that this paper merely evaluates
the activity of SChE in the presence of diazinon. SChE is
mainly composed of BChE, which is used as a biomarker
of exposure to OPIs. This paper does not evaluate OPinduced respiratory muscle impairment at neuromuscular
junctions due to AChE inhibition, which would be
indirectly measured as EChE activity in red blood cells
(20), a biomarker of measuring AChE activity in the
nervous system. Therefore, the empirically determined
SChE activities presented in Table 1 should not be
correlated to AChE inhibition in the nerve tissue.
SChE is more labile than EChE and, thus, SChE activity
would drop the most rapidly in response to exposure to an
OPI, making SChE a good and cost-effective biomarker
of acute OPI poisoning. As the aim of this work was to
monitor only the acute effects of exposure to OPI in the
short-term, not the chronic effects of exposure to OPI in
the long-term, only SChE activities were tested in animals.
To gain more structural insight into human ChE
enzymes, the crystal structures of human BChE [PDB
ID: 2WID (15)], white in Figure 4, and of human AChE
[PDB ID: 3LII (21)], red in Figure 4, were superposed,
which gave rise to a 52.36% sequence identity and a high
degree of structural similarity in the binding site. In
particular, the locations of the catalytic histidine (HIS)
and serine (SER) amino acid residues are well preserved
in the binding sites of human BChE and human AChE.
Furthermore, the docking of ACh, diazinon, and CAPE
into the binding site of human AChE revealed that CAPE

SER198
ACh
HIS438

HIS

CYS

CAPE

Figure 3. Docked structures of CAPE and ACh in the catalytic
binding site of BChE, in which the ligand surface volumes are
transparently colored in magenta and cyan, respectively.

Figure 4. Superposed crystal structures of human BChE (white,
PDB ID: 2wid) and human AChE (red, PDB ID: 3lii). Positions of
catalytic HIS (HIS438 for BChE and HIS447 for AChE) and SER
(SER198 for BChE and SER203 for AChE) residues are marked.
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binds with greater affinities than does diazinon (Table 3).
Indeed, it was computationally found that CAPE binds to
AChE with greater affinity than it does to BChE; see Tables
2 and 3 for CAPE’s association constants.
In silico findings strongly suggest that human AChE and
BChE are structurally very similar and that it is highly likely
that CAPE protects AChE inhibition by OPIs in the nerve
cells. However, in order to support such a putative conclusion,
further animal and biochemistry experiments are in progress
to monitor EChE activities in presence of OPs.
In conclusion, the animal, biochemistry, and in silico
results presented in this paper suggest that CAPE exhibits
the best protective effects against BChE inhibition by OPIs

if it is applied prior to exposure to OP. Therefore, it is
highly recommended that natural beeswax or CAPE itself
be used as a precautionary natural antidote by farmers and
workers prior to dealing with OPIs in order to diminish
the acute effects of SChE inhibition; however, the use of
CAPE requires further safety studies.
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